Xinling Pharmaceutical
Guangdong
About Xinling Pharmaceutical
Xinling Pharmaceutical is a formulation technology developer for the transdermal patch and oral film. They develops transdermal patch and oral film drug products with lower toxicity, higher efficacy, and better patient compliance over other dosage forms.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $15.7M
- Funding stage: Seed
- Last round: Seed (Mar 2022)
- Website: novastagepharma.com
- Phone: 86-0755-33522766
Industries & Categories
Medical, Pharmaceutical, Product Research
Canonical: https://fsome.com/organization/xinling-pharmaceutical-62004 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.